What the research found

The association between high HDL cholesterol and cardiovascular protection, established through decades of population-level epidemiology, has not translated into clinical benefit when researchers have attempted to artificially raise HDL-C. Multiple large trials using drugs designed to increase HDL-C (including niacin, fibrates, and CETP inhibitors) failed to reduce heart attacks or other major adverse cardiovascular events, despite successfully elevating the blood marker. This disconnect suggests that HDL-C—the cholesterol mass measured in standard blood tests—is a poor proxy for what actually protects against atherosclerosis.

The core issue is that HDL-C measures only the total amount of cholesterol carried in HDL particles, not the number of particles present, their composition, or their functional capacity. HDL particles perform dozens of distinct biological functions beyond cholesterol removal, but clinicians have no standardised functional assay to assess these capabilities. The field has essentially confused a convenient lab number with the underlying biology it was meant to represent.

Why it matters for you

If you're optimising your health through blood work, an isolated HDL-C reading above 60 mg/dL shouldn't reassure you the way conventional wisdom suggests. The case presented—a 70-year-old with HDL-C over 100 mg/dL who nonetheless had significant coronary stenosis—illustrates this directly. A "good" HDL number can coexist with atherosclerotic disease, and relying on it as your primary reassurance is risky.

More practically: focus instead on the metabolic context surrounding your lipid panel. Low HDL-C often clusters with elevated triglycerides, high fasting glucose, and other signs of insulin resistance—these are the risk factors that matter. Conversely, if your HDL-C is elevated alongside good metabolic markers (low triglycerides, good glucose control, favourable inflammatory biomarkers), that constellation of health is what's protective, not the HDL number itself. The real work happens through training, sleep quality, dietary consistency, and managing visceral fat—the levers that improve your entire metabolic profile.

This also means chasing HDL-C upward through supplements or lifestyle tweaks aimed specifically at raising that number is unlikely to help your cardiovascular health. Better to pursue genuine metabolic resilience and let your lipid panel reflect that underlying improvement.

Caveats

• Trial data on HDL-raising drugs is now decades old; newer evidence could shift the picture
• No functional HDL assay is currently available in clinical practice, making it difficult to know what "good" HDL particles look like in individuals
• The epidemiological association between higher HDL-C and lower cardiovascular risk remains real at the population level; the causal mechanism appears to be elsewhere